Medical White Papers

RSS

Medical White Papers are in-depth articles aimed to educate and inform site visitors interested in medical research. Some of these papers are derived from sources where we have existing commercial relationships. Such articles are clearly labelled as sponsored content and are only accepted when the content is deemed to add value to the core editorial ethos of News Medical.

Autism spectrum disorder (ASD) and its early diagnosis via infant behavior measurements

This article describes the potential diagnosis of ASD in infants as young as 12 months via measuring infant behavior.

From Noldus Information Technology 29 Nov 2022

Forecasting solution as a solid foundation for forecasting pipeline assets

J+D was approached by a global pharmaceutical company that needed a new forecasting solution with a robust process management system to give it a solid foundation when forecasting its pipeline assets

From J+D Forecasting 22 Nov 2022

Overcoming the inherent inaccuracy of long-range pharmaceutical forecasting

This article looks at how to use strategies to overcome the inherent inaccuracy of long-range pharma forecasting.

From J+D Forecasting 22 Nov 2022

Providing a bright future with cell therapies

Cell therapies have been getting a great deal of attention as of late—most notably, gene-modified cell therapies for cancer immunology, such as CAR T therapies.

From Corning Life Sciences 22 Nov 2022

The possibilities of stem cell therapies

This article explores the possibilities of stem cell therapies.

From Corning Life Sciences 22 Nov 2022

Physical activity and iron: Tips for those who practice sport

This article talks about how to handle physical activity in case of an iron deficiency.

From PharmaNutra Spa 22 Nov 2022

Surface finishing techniques for medical implants

Medical implants are in ever-growing demand, and manufacturers need to find more efficient surface finishing techniques for the medical industry.

From Kemet International Ltd 21 Nov 2022

Using Chinese hamster ovary cells as a bioprocessing tool

This article describes the importance of Chinese Hamster Ovary cells (CHO cells) for scientific discovery and bioprocessing.

From GenScript 16 Nov 2022

Treating hematologic malignancies with engineered T cells

This article explores new targets in solid tumors for treating patients with hematologic malignancies.

From GenScript 16 Nov 2022

mRNA technology to treat a variety of solid tumors

This article assesses the efficacy and persistence of a self-amplified mRNA vaccine system for treating advanced metastatic solid tumors.

From GenScript 16 Nov 2022

The advantages of developing rabbit antibodies

This article describes the advantages of the development of Rabbit Antibodies for applications such as Western Blot, ELISA, Immunostaining, diagnostics, and therapeutical applications.

From GenScript 16 Nov 2022

A gene based strategy to prevent the progression of non-alcoholic fatty liver disease (NAFLD)

This article describes the clinical studies into NAFLD and the gene delivery approach to target lipid oxidation.

From GenScript 16 Nov 2022

The advantages of RNA technology for drug development

In this article, the key advantages of mRNA, as opposed to other macromolecules such as DNA and proteins, for therapeutic strategies are discussed.

From GenScript 16 Nov 2022

Facilitating antibody-drug and vaccine development with CRISPR/Cas editing tools

This article describes a new development of CRISPR/Cas editing tools that facilitates the peptide library analysis workflow.

From GenScript 16 Nov 2022

Choosing your platform for cell culture scale-up: suspension or adherent?

When deciding on a cell culture method, two methods should be considered: cell suspension and adherent cell surface.

From Corning Life Sciences 16 Nov 2022

Scaling anchorage-dependent cells for allogenic cell therapies

Discover why primary cell cultures are necessary for establishing cell lines.

From Corning Life Sciences 16 Nov 2022

The complexity of cell and gene therapy products and manufacturing processes

Due to the inherent complexity of cell and gene therapy products and manufacturing processes, it is crucial for sponsors to conduct due diligence before committing to a partner.

From Corning Life Sciences 16 Nov 2022